Literature DB >> 24939760

'Acute shift in glutamate-concentrations following experimentally induced panic with cholecystokinin-tetrapeptide-a 3T-MRS study in healthy subjects'-a reply to the letter to the editor.

Peter Zwanzger1, Alexander Yassouridis2, Bettina Pfleiderer3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24939760      PMCID： PMC4207332          DOI： 10.1038/npp.2014.104

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN： 0893-133X            Impact factor:   7.853


× No keyword cloud information.
  6 in total

1.  The role of the beta-noradrenergic system in cholecystokinin-tetrapeptide-induced panic symptoms.

Authors:  J M Le Mellédo; J Bradwejn; D Koszycki; D G Bichet; F Bellavance
Journal:  Biol Psychiatry       Date:  1998-09-01       Impact factor: 13.382

2.  Glutamate changes in anterior cingulate cortex following CCK-4 infusion.

Authors:  Richard J Maddock
Journal:  Neuropsychopharmacology       Date:  2014-06-18       Impact factor: 7.853

3.  Aging and panicogenic response to cholecystokinin tetrapeptide: an examination of the cholecystokinin system.

Authors:  Alastair Flint; Jacques Bradwejn; Franco Vaccarino; Jolanta Gutkowska; Roberta Palmour; Diana Koszycki
Journal:  Neuropsychopharmacology       Date:  2002-10       Impact factor: 7.853

4.  CCK-B receptor gene and response to cholecystokinin-tetrapeptide in healthy volunteers.

Authors:  Diana Koszycki; Zoe Prichard; Alexandra J Fiocco; Jakov Shlik; James L Kennedy; Jacques Bradwejn
Journal:  Peptides       Date:  2012-03-10       Impact factor: 3.750

5.  Acute and chronic role of 5-HT3 neuronal system on behavioral and neuroendocrine changes induced by intravenous cholecystokinin tetrapeptide administration in humans.

Authors:  M Dépôt; G Caillé; J Mukherjee; M A Katzman; A Cadieux; J Bradwejn
Journal:  Neuropsychopharmacology       Date:  1999-02       Impact factor: 7.853

6.  Acute shift in glutamate concentrations following experimentally induced panic with cholecystokinin tetrapeptide--a 3T-MRS study in healthy subjects.

Authors:  Peter Zwanzger; Maxim Zavorotnyy; Elena Gencheva; Julia Diemer; Harald Kugel; Walter Heindel; Tillmann Ruland; Patricia Ohrmann; Volker Arolt; Katharina Domschke; Bettina Pfleiderer
Journal:  Neuropsychopharmacology       Date:  2013-03-05       Impact factor: 7.853
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.